MUSCLELOCK^®

Burn Fat & Build Muscle.

Advanced Lean Mass Support

Engineered for GLP-1 Protocols & Active Weight Management

→ Activates mTOR to initiate muscle protein synthesis

→ Inhibits MuRF1 & Atrogin-1 proteolytic breakdown enzymes

→ Supports mitochondrial ATP output and metabolic efficiency

→ ESD-X3 electrostatic dispersion for enhanced cellular absorption

Enter the Molecular Experience Explore the Protocol

Muscle at risk
during GLP therapy

Clinically-studied
active ingredients

Metabolic pathways
targeted simultaneously

Scroll

20–50% of weight lost during GLP therapy may come from lean muscle ◆ L-Leucine activates mTOR — the master regulator of protein synthesis ◆ Beta-Ecdysterone upregulates PI3K/AKT anabolic signaling ◆ Maslinic Acid inhibits MuRF1 & Atrogin-1 proteolytic enzymes ◆ Vitamin D3 increases mitochondrial efficiency and ATP production ◆ ESD-X3 uses electrostatic forces for enhanced cellular absorption ◆ Formulated by Richard Goldfarb, MD, FACS · Board-Certified Surgeon ◆ 20–50% of weight lost during GLP therapy may come from lean muscle ◆ L-Leucine activates mTOR — the master regulator of protein synthesis ◆ Beta-Ecdysterone upregulates PI3K/AKT anabolic signaling ◆ Maslinic Acid inhibits MuRF1 & Atrogin-1 proteolytic enzymes ◆ Vitamin D3 increases mitochondrial efficiency and ATP production ◆ ESD-X3 uses electrostatic forces for enhanced cellular absorption ◆ Formulated by Richard Goldfarb, MD, FACS · Board-Certified Surgeon ◆

The Problem

Weight Loss Has
a Hidden Cost.

GLP-1 receptor agonists have transformed metabolic medicine. Millions of patients are achieving significant, sustained weight reduction. But aggressive weight loss introduces a physiological challenge that is consistently overlooked in clinical practice.

Weight loss does not occur exclusively from fat. During GLP-based therapy or caloric restriction, the body's catabolic response breaks down both fat tissue and lean muscle. Research and clinical observation suggest 20–50% of weight lost may come from lean muscle — not fat.

→

Reduced metabolic rate — Lean muscle is metabolically active. Its loss lowers baseline caloric expenditure and accelerates rebound weight gain.

→

Loss of strength & function — Muscle mass is essential for mobility, stability, and quality of life at every age.

→

Worsening insulin resistance — Skeletal muscle is a primary site of glucose uptake. Reduced mass correlates directly with metabolic dysfunction.

→

Accelerated metabolic aging — Progressive muscle loss drives sarcopenia and age-related metabolic decline.

Typical Body Composition During GLP-1 Therapy

Weight loss source breakdown

Fat Loss

50–80%

Muscle Loss

20–50%

Source: Clinical literature on body composition during GLP-1 receptor agonist therapy and caloric restriction protocols.

35 lbs

Of a 50 lb weight loss, up to 17 lbs may be lean muscle

Explore the Biology

See exactly how muscle breakdown happens at the cellular level.

Enter the Molecular Experience →

Immersive Science Experience

A Cinematic Journey
Through the Biology
of Muscle Preservation.

Scroll through 12 scientifically-grounded scenes — from the surface of a fat cell to the interior of a ribosome. Watch mTOR activate, protein chains assemble, and muscle fibers expand in real time.

01 →Fat cell lipolysis & lipid release

03 →MuRF1 enzyme muscle degradation

04 →ESD-X3 electrostatic dispersion

07 →mTOR cascade activation sequence

08 →Ribosome protein chain assembly

12 →Complete metabolic activation

Enter the Molecular Flythrough →

LIVE PREVIEW 12 Scenes · 90s · WebGL

0:00 / 1:30 Enter Full Experience →

The MuscleLock Protocol

Four Ingredients.
Five Metabolic Pathways.

Each compound targets a distinct biological mechanism. Together they form an integrated muscle-preservation system.

L-Leucine

mTOR Activation

The primary anabolic trigger. Leucine binds to the Sestrin2 nutrient sensor, relieving mTOR inhibition and initiating the muscle protein synthesis cascade.

Leucine → Sestrin2 sensor

→ mTORC1 activation

→ Ribosome assembly

→ Protein synthesis ↑

Beta-Ecdysterone

PI3K / AKT Pathway

Activates the PI3K → AKT → mTOR anabolic axis from a second upstream signal, amplifying the protein synthesis cascade through a complementary mechanism.

PI3K activation

→ AKT phosphorylation

→ mTOR amplification

→ Anabolic output ↑↑

Maslinic Acid

MuRF1 Inhibition

Suppresses the MuRF1 and Atrogin-1 ubiquitin ligases — the enzymes that tag muscle proteins for proteolytic degradation. Maslinic acid acts as a molecular shield.

MuRF1 inhibition

→ Atrogin-1 suppression

→ Protein degradation ↓

→ Lean muscle preserved

Vitamin D3

Mitochondrial Efficiency

Activates the nuclear Vitamin D receptor → Irisin signaling pathway, directly increasing mitochondrial efficiency and sustaining the ATP output required for anabolic metabolism.

VDR activation

→ Irisin signaling

→ Mitochondrial efficiency ↑

→ ATP production ↑

ESD-X3 Delivery Technology

Electrostatic Dispersion System dramatically increases nutrient surface area for enhanced cellular uptake across three absorption channels.

Learn More →

Biochemical Mechanisms

Three Systems.
One Integrated Result.

Pathway 01 — Activate

mTOR Protein Synthesis

Leucine and Beta-Ecdysterone converge on mTORC1 from two distinct upstream pathways. mTOR phosphorylates S6K and releases 4EBP1 inhibition, activating ribosomes to translate mRNA into structural muscle proteins.

v = V_max · [Leucine] / (K_m + [Leucine])

H = k · mTOR · ATP · Ribosome

Pathway 02 — Protect

MuRF1 Enzyme Inhibition

Maslinic acid directly suppresses the MuRF1 and Atrogin-1 ubiquitin ligases. These enzymes attach ubiquitin tags to muscle proteins, marking them for proteasomal degradation. Inhibition prevents this signal from being executed.

Rate_breakdown = k · [MuRF1] · [Protein]

Maslinic Acid → [MuRF1] → 0

Pathway 03 — Energize

Mitochondrial ATP Support

Vitamin D3 increases mitochondrial efficiency, sustaining ATP output for anabolic metabolism. AMPK monitors the AMP/ATP ratio — with sufficient mitochondrial energy, AMPK stays inactive, freeing mTOR to drive muscle growth.

AMPK inactive ∴ mTOR active ∴ growth

Protein_synthesis > Protein_breakdown

mTOR

Leu

AKT

AMPK

Ribo

Mito

MuRF1

Interactive 3D · Click any node · Ingredient injection

Interactive Simulation

Navigate the
Living Metabolic
Network.

The Matrix Metabolic Atlas renders every MuscleLock signaling pathway as a 3D holographic network inside a virtual cell. Click nodes to explore pathways. Inject ingredients and watch the cascade propagate in real time.

12 interactive pathway nodes

11 biochemical signal edges

50k GPU particle molecules

4 injectable ingredients

Explore the Metabolic Atlas →

Clinical Evidence

The Numbers Behind the Science.

20–50%

of weight lost during GLP therapy may come from lean muscle mass

clinically-studied active ingredients in a single protocol

distinct metabolic pathways targeted simultaneously

3×

ESD-X3 absorption channels for enhanced bioavailability

The GLP-1 Challenge

Rapid Weight Loss Accelerates Catabolism

Aggressive caloric restriction upregulates the ubiquitin-proteasome degradation pathway. MuRF1 and Atrogin-1 enzyme levels increase, directly dismantling muscle protein structure for use as an alternative energy source.

mTOR Biology

Protein Synthesis Requires Constant Signaling

Muscle protein synthesis is not passive. It requires continuous activation of the mTOR complex, adequate amino acid availability, and sustained ATP energy — all three of which are compromised during weight loss without targeted supplementation.

Multi-Pathway Design

Single-Mechanism Products Fail at Scale

Muscle preservation during significant weight loss cannot be achieved by targeting one pathway. MuscleLock simultaneously activates anabolic signaling, inhibits catabolic enzymes, and supports the energy infrastructure required to sustain both systems.

Delivery Technology

ESD-X3
Electrostatic Dispersion.

Superior ingredients require superior delivery. ESD-X3 applies electrostatic forces to disperse nutrient molecules at the microscopic level, increasing surface area and dramatically improving cellular uptake efficiency across three distinct absorption channels.

Electrostatic Dispersion

Electrostatic charges separate nutrient molecules at the microscopic level, preventing clumping and maximizing bioavailable surface area.

Cellular Membrane Interaction

Optimized particle charge profiles facilitate interaction with phospholipid bilayer membranes, enhancing passive transport across cell walls.

Enhanced Absorption Channels

Three distinct absorption pathways — paracellular, transcellular, and carrier-mediated — are activated simultaneously for comprehensive nutrient uptake.

Who It's For

Engineered for Those Who
Refuse to Compromise.

Highest-Growth Segment

GLP-1 Patients

Individuals on semaglutide, tirzepatide, or similar GLP-1 receptor agonists who want to ensure their weight loss comes from fat — not muscle.

Anabolic protection during aggressive weight loss

Active Aging

Adults 50–65

Active adults experiencing age-related muscle decline. MuscleLock provides targeted metabolic support to maintain strength, energy, and lean composition through midlife transition.

Sarcopenia prevention & metabolic support

Body Recomposition

Athletes Cutting

Competitive athletes and fitness-focused individuals managing body composition during caloric restriction phases who need to preserve performance-critical lean mass.

Muscle preservation during caloric deficit

Women 40+

Menopause & Metabolic Shift

Women navigating hormonal changes associated with perimenopause and menopause, during which accelerated muscle loss and shifting body composition present significant metabolic challenges.

Hormonal metabolic transition support

MD, FACS Board-Certified Surgeon Nutritional Biochemistry Delivery Technology

The Formulator

Richard Goldfarb,
MD, FACS.

Dr. Richard Goldfarb is a board-certified surgeon and recognized authority in nutritional biochemistry and advanced delivery technology. His clinical career spans decades of work at the intersection of surgical medicine and metabolic science.

MuscleLock represents a clinical philosophy refined over years of observing the metabolic consequences of surgical weight loss, GLP therapy, and aging in real patients. Its formulation is built on multi-mechanistic thinking — addressing the problem at the pathway level, not the symptom level.

The goal was never just weight loss. It was weight loss that preserved everything that matters — the lean tissue that gives you strength, metabolism, and vitality.

— Richard Goldfarb, MD, FACS

Join the Study

The Matrix
Transformation Study.

A structured 12-week protocol tracking body composition, lean mass retention, and metabolic markers. Document your transformation with before/after photography, detailed measurements, and progress analytics.

Week Protocol

Measurement Phases

100%

Science-Backed

Begin the Transformation Study →

Baseline Documentation

Body measurements, photography, and metabolic baseline.

12-Week Protocol

Daily tracking, weekly check-ins, and progress analytics.

Results Analysis

Lean mass retention, body composition, metabolic outcomes.

MUSCLELOCK®

Weight Loss Hasa Hidden Cost.

A Cinematic JourneyThrough the Biologyof Muscle Preservation.

Four Ingredients.Five Metabolic Pathways.

Three Systems.One Integrated Result.